Global Feline Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Feline Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Feline vaccinations stimulate your kitten or cat's immune system in order to create protection from specific infectious diseases. This can cause mild symptoms to occur ranging from soreness at the injection site to fever and allergic reactions.
Feline Vaccines report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Feline Vaccines market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Prevention of Feline Panleukopaenia and Prevention of Feline Rhinotracheitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Feline Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Feline Vaccines key manufacturers include Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac and Kyoto Biken Laboratories, etc. Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer) are top 3 players and held % sales share in total in 2022.
Feline Vaccines can be divided into F3 (FVRCP) Vaccination, Feline Leukaemia Vaccination, Rabies Vaccination and Heartworm Vaccination, etc. F3 (FVRCP) Vaccination is the mainstream product in the market, accounting for % sales share globally in 2022.
Feline Vaccines is widely used in various fields, such as Prevention of Feline Panleukopaenia, Prevention of Feline Rhinotracheitis, Prevention of Feline Calicivirus and Others, etc. Prevention of Feline Panleukopaenia provides greatest supports to the Feline Vaccines industry development. In 2022, global % sales of Feline Vaccines went into Prevention of Feline Panleukopaenia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Feline Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co
Boehringer Ingelheim International
Zoetis (Pfizer)
Elanco Animal Health
Virbac
Kyoto Biken Laboratories
Segment by Type
F3 (FVRCP) Vaccination
Feline Leukaemia Vaccination
Rabies Vaccination
Heartworm Vaccination
Others
Prevention of Feline Panleukopaenia
Prevention of Feline Rhinotracheitis
Prevention of Feline Calicivirus
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Feline Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Feline Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Feline Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Feline Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Feline Vaccines introduction, etc. Feline Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Feline Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
Feline Vaccines report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Feline Vaccines market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Prevention of Feline Panleukopaenia and Prevention of Feline Rhinotracheitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Feline Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Feline Vaccines key manufacturers include Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac and Kyoto Biken Laboratories, etc. Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer) are top 3 players and held % sales share in total in 2022.
Feline Vaccines can be divided into F3 (FVRCP) Vaccination, Feline Leukaemia Vaccination, Rabies Vaccination and Heartworm Vaccination, etc. F3 (FVRCP) Vaccination is the mainstream product in the market, accounting for % sales share globally in 2022.
Feline Vaccines is widely used in various fields, such as Prevention of Feline Panleukopaenia, Prevention of Feline Rhinotracheitis, Prevention of Feline Calicivirus and Others, etc. Prevention of Feline Panleukopaenia provides greatest supports to the Feline Vaccines industry development. In 2022, global % sales of Feline Vaccines went into Prevention of Feline Panleukopaenia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Feline Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co
Boehringer Ingelheim International
Zoetis (Pfizer)
Elanco Animal Health
Virbac
Kyoto Biken Laboratories
Segment by Type
F3 (FVRCP) Vaccination
Feline Leukaemia Vaccination
Rabies Vaccination
Heartworm Vaccination
Others
Segment by Application
Prevention of Feline Panleukopaenia
Prevention of Feline Rhinotracheitis
Prevention of Feline Calicivirus
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Feline Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Feline Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Feline Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Feline Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Feline Vaccines introduction, etc. Feline Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Feline Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.